Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma (Q44551425)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma |
scientific article published in March 2004 |
Statements
1 reference
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma (English)
1 reference
1 reference
Janice P Dutcher
1 reference
Michael B Atkins
1 reference
Walter M Stadler
1 reference
Theodore F Logan
1 reference
Gary R Hudes
1 reference
Young Park
1 reference
Song-Heng Liou
1 reference
Bonnie Marshall
1 reference
Joseph P Boni
1 reference
Gary Dukart
1 reference
Matthew L Sherman
1 reference
1 March 2004
1 reference
1 reference
1 reference
Identifiers
1 reference